VistaGen Therapeutics, Inc. (VTGN) NASDAQ

Currency In USD

AD

Valuation

Market Cap21.76M
Enterprise Value-7.99M
P/E Ratio-0.34
PEG Ratio0.03
Price/Sales Ratio16.53
Price/Book Ratio0.69
Enterprise/Revenue-6.91
Enterprise/EBITDA0.13

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-54.91
Operating Margin-56.84
AD

Management Effectiveness

Return On Assets-1.43
Return On Equity-1.33

Income Statement

Revenue1.27M
Revenue/Share0.03
Gross Profit1.27M
EBITDA-71.39M
Net Income-69.69M
Diluted EPS-1.83

Balance Sheet

Total Cash45.4M
Total Cash/Share1.19
Total Debt1.04M
Total Debt/Equity0.03
Current Ratio3.67
Book Value Per Share0.93

Price History

52-Week Change-67.35
52-Week High5.14
52-Week Low0.43
Moving Average 50 Days0.61
Moving Average 200 Days1.85

Statistics

Average Volume878,891
Shares Outstanding32.77M
% Held by Institutions34.88

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:30
Last Split DateJune 07, 2023
AD